31.35
Oscar Health Inc stock is traded at $31.35, with a volume of 2.86M.
It is down -4.09% in the last 24 hours and up +7.97% over the past month.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
See More
Previous Close:
$32.76
Open:
$32.22
24h Volume:
2.86M
Relative Volume:
0.44
Market Cap:
$9.67B
Revenue:
$13.30B
Net Income/Loss:
$-39.39M
P/E Ratio:
-51.42
EPS:
-0.6096
Net Cash Flow:
$2.80B
1W Performance:
+13.55%
1M Performance:
+7.97%
6M Performance:
+134.64%
1Y Performance:
+100.89%
Oscar Health Inc Stock (OSCR) Company Profile
Name
Oscar Health Inc
Sector
Industry
Phone
(646) 403-3677
Address
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OSCR
Oscar Health Inc
|
31.33 | 10.11B | 13.30B | -39.39M | 2.80B | -0.6096 |
|
UNH
Unitedhealth Group Inc
|
394.37 | 360.59B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
94.15 | 124.26B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
390.26 | 86.82B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
275.15 | 74.66B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
383.54 | 46.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-04-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-06-26 | Initiated | Wolfe Research | Peer Perform |
| Apr-20-26 | Upgrade | Jefferies | Underperform → Hold |
| Feb-12-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-09-26 | Upgrade | UBS | Sell → Neutral |
| Jan-05-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-11-25 | Initiated | Stephens | Equal-Weight |
| Nov-26-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-15-25 | Downgrade | UBS | Neutral → Sell |
| Jul-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-11-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-02-25 | Initiated | Barclays | Underweight |
| Jun-24-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-13-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-24 | Initiated | Jefferies | Underperform |
| Nov-06-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-07-24 | Initiated | UBS | Neutral |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-22-24 | Initiated | Raymond James | Outperform |
| Nov-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-14-22 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-14-21 | Initiated | Goldman | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Mar-30-21 | Initiated | Wells Fargo | Overweight |
| Mar-29-21 | Initiated | BofA Securities | Buy |
| Mar-29-21 | Initiated | Cowen | Market Perform |
| Mar-29-21 | Initiated | Credit Suisse | Outperform |
| Mar-29-21 | Initiated | Goldman | Buy |
| Mar-29-21 | Initiated | Morgan Stanley | Overweight |
View All
Oscar Health Inc Stock (OSCR) Latest News
OSCR Looks 37.8% Overvalued on GF Value™ as Momentum and Growth Shine - GuruFocus
Oscar Health, Inc. (OSCR) Investor Outlook: Evaluating Strong Revenue Growth Amid High RSI Levels - directorstalkinterviews.com
Empowered Funds LLC Invests $6.23 Million in Oscar Health, Inc. $OSCR - MarketBeat
HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace - Stocktwits
Oscar Health (OSCR) Is Up 17.4% After Swinging To Profit And Raising 2026 GuidanceWhat's Changed - simplywall.st
Royal Bank of Canada Acquires 119,714 Shares of Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health, Inc. $OSCR Shares Purchased by Bank of America Corp DE - MarketBeat
OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance - Stocktwits
Is Oscar Health (OSCR) Undervalued After Its Earnings Beat And Guidance Raise? - Yahoo Finance
Can Oscar Health (OSCR) Still Look Cheap After Strong Q2? - Yahoo Finance
Oscar Health’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo! Finance Canada
Oscar Health (NYSE:OSCR) Reaches New 52-Week HighTime to Buy? - MarketBeat
Why Is OSCR Stock Rising Today? - Stocktwits
OSCR Stock On Track For 6-Month High: What’s Driving This Earnings Rally? - Stocktwits
Why Oscar Health (OSCR) Stock Is Up Today - Quiver Quantitative
Oscar Health Inc Stock (OSCR) Moved Up by 7.22% on Aug 14: What Investors Need To Know - TradingKey
Oscar Health stock hits 52-week high at 33.12 USD By Investing.com - Investing.com Australia
Oscar Health stock hits 52-week high at 33.12 USD - Investing.com
Oscar Health (NYSE:OSCR) Shares Up 7.1% on Analyst Upgrade - MarketBeat
Why Did Oscar Health (OSCR) Fall After Record Profit and a Guidance Hike? - Yahoo Finance
Is Oscar Health Inc (OSCR) Overvalued After 4.0% Rally? GF Value - GuruFocus
Q2 Earnings Roundup: Oscar Health (NYSE:OSCR) And The Rest Of The Health Insurance Providers Segment - Yahoo Finance
OSCR Maintained by Wells Fargo -- Price Target Raised to $27 - GuruFocus
Wells Fargo & Company Forecasts Strong Price Appreciation for Oscar Health (NYSE:OSCR) Stock - MarketBeat
Quantinno Capital Management LP Raises Stock Position in Oscar Health, Inc. $OSCR - MarketBeat
Annex Advisory Services LLC Decreases Stock Position in Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health, Inc. (OSCR) stock price, news, quote and history - Yahoo Finance Singapore
Oscar Health Inc (OSCR) Shares Surge 5.9% -- What GF Score of 76 Tells Investors - GuruFocus
Wedge Capital Management L L P NC Takes Position in Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health (NYSE:OSCR) Displays Accelerating Growth and Improving Fundamentals - ChartMill
(OSCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
1 Unpopular Stock That Deserves Some Love and 2 We Avoid - Yahoo Finance UK
Results: Oscar Health, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - webull.com
Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History - Yahoo! Finance Canada
OSCR Price Today: Oscar Health, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
California State Teachers Retirement System Has $2.70 Million Stake in Oscar Health, Inc. $OSCR - MarketBeat
CoxHealth enters ACA partnership - Springfield Business Journal
Oscar Health, Inc. (OSCR) Stock Analysis: Impressive Revenue Growth and What It Means for Investors - directorstalkinterviews.com
Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Oscar Health, Inc. (OSCR) Interactive Stock Chart - Yahoo! Finance Canada
OSCR Q2 Deep Dive: Individual Market Growth and AI Investments Shape Outlook - Yahoo Finance
Why Oscar Health (OSCR) Is Down 10.6% After Swinging to Q2 Profit and Raising 2026 Guidance - simplywall.st
Oscar Health Q2 Earnings Call Highlights - MarketBeat
Oscar Health (OSCR) Q2 2026 Earnings Call Transcript - webull.com
Oscar Health (OSCR) Stock Jumps As Margins Power A Profit Breakthrough - simplywall.st
OSCAR HEALTH INC. : BARCLAYS RAISES TARGET PRICE TO $39 FROM $35 - webull.com
Oscar Health (NYSE:OSCR) Posts Earnings Results, Beats Estimates By $0.70 EPS - marketbeat.com
Is Oscar Health Inc (OSCR) Overvalued After 5.1% Rally? GF Value - GuruFocus
Oscar Health (NYSE:OSCR) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
OSCR Maintained by Barclays -- Price Target Raised to $39 - GuruFocus
Oscar Health | 10-Q: Q2 2026 Earnings Report - Moomoo
Oscar Health Inc Stock (OSCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):